Loading stock data…
Loading stock data…
US$5.75
Get one email when NUVB crosses your level. Checked every 15 minutes during market hours.
▼ -0.15 (-2.54%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
54.6
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
0.20
Bearish momentumMACD below its signal line (0.22).
50-day average
5.17
Price aboveShort-term trend reference.
200-day average
5.55
Price aboveLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Nuvation Bio Inc. is a commercial-stage biopharmaceutical company specializing in oncology therapies. The company focuses on cancers with clear molecular drivers and high unmet medical need, emphasizing precision oncology for difficult-to-treat solid tumors. Its current portfolio centers on targeted small-molecule drugs, including taletrectinib, a next-generation ROS1 inhibitor marketed for ROS1-positive non-small cell lung cancer, and safusidenib, a brain-penetrant inhibitor of mutant IDH1 desi…
www.nuvationbio.com4 strong buy · 11 buy · 2 hold · 0 sell · 0 strong sell (17 analysts, 2026-07-01)
4 strong buy · 11 buy · 2 hold · 0 sell · 0 strong sell (17 analysts, 2026-06-01)
4 strong buy · 11 buy · 2 hold · 0 sell · 0 strong sell (17 analysts, 2026-05-01)
4 strong buy · 11 buy · 2 hold · 0 sell · 0 strong sell (17 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-06-01 | 2.28 | 3.23 | ✓ Beat |
| 2026-05-04 | — | 0.01 | — |
| 2026-03-02 | -0.04 | -0.09 | ✗ Miss |
| 2025-11-03 | -0.17 | -0.16 | ✓ Beat |
| 2025-08-07 | -0.14 | -0.14 | ✓ Beat |
Companies in the same industry, via Finnhub